A phase II trial of imatinib mesylate monotherapy in patients with metastatic breast cancer.
Modi S, Seidman AD, Dickler M, Moasser M, D'Andrea G, Moynahan ME, Menell J, Panageas KS, Tan LK, Norton L, Hudis CA.
Modi S, et al. Among authors: panageas ks.
Breast Cancer Res Treat. 2005 Mar;90(2):157-63. doi: 10.1007/s10549-004-3974-0.
Breast Cancer Res Treat. 2005.
PMID: 15803362
Clinical Trial.